key: cord-0913063-2wphiplw
authors: Bardelčíková, Annamária; Miroššay, Andrej; Šoltýs, Jindřich; Mojžiš, Ján
title: Therapeutic and prophylactic effect of flavonoids in post‐COVID‐19 therapy
date: 2022-03-18
journal: Phytother Res
DOI: 10.1002/ptr.7436
sha: 99dab6bb591d4130fac7c684c41107ae2ed61c42
doc_id: 913063
cord_uid: 2wphiplw

The high incidence of post‐covid symptoms in humans confirms the need for effective treatment. Due to long‐term complications across several disciplines, special treatment programs emerge for affected patients, emphasizing multidisciplinary care. For these reasons, we decided to look at current knowledge about possible long‐term complications of COVID‐19 disease and then present the effect of flavonoids, which could help alleviate or eliminate complications in humans after overcoming the COVID‐19 infection. Based on articles published from 2003 to 2021, we summarize the flavonoids‐based molecular mechanisms associated with the post‐COVID‐19 syndrome and simultaneously provide a complex view regarding their prophylactic and therapeutic potential. Review clearly sorts out the outcome of post‐COVID‐19 syndrome according particular body systems. The conclusion is that flavonoids play an important role in prevention of many diseases. We suggest that flavonoids as critical nutritional supplements, are suitable for the alleviation and shortening of the period associated with the post‐COVID‐19 syndrome. The most promising flavonoid with noteworthy therapeutic and prophylactic effect appears to be quercetin.

probably the key question to address.

Studies show that COVID-19 is induced by a SARS-CoV-2 virus, which attaches to its S protein's angiotensin-converting enzyme 2 (ACE2) receptor. Present on the surface of host respiratory cells (Jia et al., 2005) such as alveolar cells type II in the lung (Hamming et al., 2004) , cells in tissues such as heart, kidney, testis (Tipnis et al., 2000) , brain, liver, intestine (Doobay et al., 2007) . The binding of the SARS-CoV-2 virus to the ACE2 receptor triggers a cascade of reactions, including inhibition of the ACE2 angiotensin II receptor, which does not change angiotensin II to angiotensin 1-7. Angiotensin II levels rise in patients' blood. Angiotensin II interacts with the AT1 receptor (angiotensin receptor) of the kidneys or blood vessels, further manifested by vasoconstriction, increased blood pressure, water retention, inflammatory reactions, and subsequent apoptosis. In the lung interstitium, angiotensin II causes apoptosis, which initiates the inflammatory process and produces inflammatory cytokines. The first aid for a patient in this condition is increased oxygen uptake by pulmonary ventilation, which is, however, insufficient in the case of socalled cytokine storm (an exaggerated autoimmune response) that causes lung damage (Rothlin, Vetulli, Duarte, & Pelorosso, 2020) ( Figure 1 ).

Since ACE2 receptors are expressed in many human tissues, including kidney epithelial cells, heart, small intestine, blood vessels, liver, endothelial cells (Hamming et al., 2004) , hematopoietic stem, and progenitor cells (Jarajapu, 2021) , they also damaged by cytokine storms. Thus, the complications associated with COVID-19 are not surprising.

COVID-19 therapy is currently mesmerizing and approached very carefully. We believe that COVID-19 treatment could be potentially more effective by understanding the interaction of SARS-CoV-2 with ACE2 receptors. Specifically, how SARS-CoV-2 inhibits its binding to the cell surface receptor. Nevertheless, the inhibition of ACE2 receptors could lead to an undesirable angiotensin II increase. Another approach to facilitating the course and outcome of COVID-19 would be using the ACE1 inhibitors, which would reduce angiotensin II level and inhibit the conversion of nonapeptide angiotensin 1-9 to heptapeptide angiotensin 1-7. This could lead hypothetically to the undesirable upregulation of ACE2 receptors and increases the possibility of SARS-CoV-2 virus binding to the cell surface. On the other hand, stimulation of ACE2 activity toward angiotensin 1-7 production could lead to an antiinflammatory effect, which would have a beneficial protective effect on the lungs and other organs possibly.

Hypothetically, the effective COVID-19 therapy, in addition to ACE2 inhibitors, should include the use of the ACE1 inhibitors, which reduce the level of angiotensin II by blocking the formation of angiotensin II from angiotensin I. Moreover, the ACE1 inhibitors converts angiotensin I to angiotensin II, which increases blood pressure. Thus, increased ACE1 activity and angiotensin II levels higher than basal levels cause hypertension and damage (Benigni, Cassis, & Remuzzi, 2010) . On the other side, these inhibitors would block both the site of interaction between SARS-CoV-2 virus and cell, as well as the renin-angiotensin signaling pathway, causing acute lung injury (Imai, Kuba, & Penninger, 2008) associated with high levels of angiotensin II.

The severity of COVID-19 is also associated with high levels of phospholipase A2. Müller et al. revealed that inhibition of cPLA2 impairs an early step of coronavirus replication in the cell culture (Müller et al., 2018) . sPLA2 group IIA (sPLA2-IIA) plays a central role in severe and fatal COVID-19 disease outcomes (Snider et al., 2021) . Snider et al. demonstrated that a high level of circulating enzymatically active secreted PLA2-IIA is an essential indicator of the COVID-19 severity. He introduced the PLA-BUN index with his team, characterized by PLA2 and blood urea nitrogen (BUN) concentration in plasma. The PLA-BUN index is a factor for mitochondrial dysfunction, sustained inflammatory injury, and lethal COVID-19. A high level of circulating catalytically active PLA2-IIA (≥10 ng/ml) is an indicator for severe COVID-19 course associated with hyperglycemia, kidney dysfunction, hypoxia, anemia, and multiple organ dysfunctions (Snider et al., 2021) . Early administration of PLA2 inhibitors represents an option to reduce COVID-19 mortality and treat the chronic inflammatory conditions in the post-COVID syndrome.

Theoretically, the drug used in COVID-19 therapy should interact with ACE2 and ACE1 receptors and have a higher affinity for ACE2 than virus affinity (SARS-CoV-2) for the ACE2. Treatment should stimulate ACE2 enzymatic activity in the active conversion of angiotensin II to angiotensin 1-7 and inhibit the ACE 1 to reduce the angiotensin II levels, and inhibits phospholipase A2 (PLA2-group IIA) F I G U R E 1 Mechanism of action of angiotensin II under physiological conditions (black arrows) and its negative effect induced by inhibition of ACE2 receptors by SARS-CoV-2 virus (green arrows). Inhibition of ACE2 receptors by SARS-CoV-2 virus binding results in a fourfold increase in angiotensin II levels, resulting in cell apoptosis followed by inflammation. As a result of the cytokine storm, acute respiratory distress syndrome development occurs. Original figure made for this review using the Zoner Photo Studio X iviral effect (Baez-Santos, St John, & Mesecar, 2015; Deng, Aluko, Jin, Zhang, & Yuan, 2012; Gong et al., 2008; L. Guerrero et al., 2012; D. P. Han, Penn-Nicholson, & Cho, 2006; Hettihewa, Hemar, & Rupasinghe, 2018; Ho, Wu, Chen, Li, & Hsiang, 2007; W. Li et al., 2003; Loizzo et al., 2007; Nguyen et al., 2012; Ojeda et al., 2010; Sui et al., 2010; Takahashi, Yoshiya, Yoshizawa-Kumagaye, & Sugiyama, 2015; M. S. Yu et al., 2012) .

Recent research teams characterized the interaction site of the S protein of the SARS-CoV-2 virus and revealed that flavonoids can bind ACE2, regulate the ACE1 and ACE2 levels, and maintain their basal levels (Bhowmik, Nandi, Prakash, & Kumar, 2021; Derosa, Maffioli, D'Angelo, & Di Pierro, 2021; El-Missiry, Fekri, Kesar, & Othman, 2021; J. Gao et al., 2021; Gour, Manhas, Bag, Gorain, & Nandi, 2021; H. Chen & Du, 2020; Cherrak, Merzouk, & Mokhtari-Soulimane, 2020; Khan et al., 2021; Mendonca & Soliman, 2020; Muchtaridi, Fauzi, Ikram, Gazzali, & Wahab, 2020; Omotuyi et al., 2021; Russo, Moccia, Spagnuolo, Tedesco, & Russo, 2020; Tutunchi, Naeini, Ostadrahimi, & Hosseinzadeh-Attar, 2020; J. W. Yu, Wang, & Bao, 2020) . In addition, disruption of the interaction between ACE2 and the SARS-CoV-2 spike protein is the main effect of flavonoids. Thus, SARS-CoV-2 cannot fuse with ACE2 (Abderrazak et al., 2015; Muchtaridi et al., 2020; J. W. Yu et al., 2020; Zhai et al., 2020) . Baicalin, scutellarin, hesperetin, nicotianamine, glycyrrhizin (H. Chen & Du, 2020) , epigallocatechin-3-gallate, theaflavin gallate (Maiti & Banerjee, 2021) , naringenin, quercetin, luteolin (Maurya, Kumar, Prasad, Bhatt, & Saxena, 2020) , fisetin, kaempferol (Pandey et al., 2020) were due to anti-SARS-CoV-2 effect and to the low toxicity selected as potential candidates for COVID-19 treatment.

Because of multisystemic disease COVID-19, many studies have been published confirming the anti-SARS-CoV-19 effect of flavonoids (Palit, Mukhopadhyay, & Chattopadhyay, 2021; Santana et al., 2021) .

The use of flavonoids is hypothetically a prerequisite for successful respiratory viral infections (Brendler et al., 2021) and COVID-19 supportive therapy. However, caution should be exercised in the conclusions, whether inhibition of ACE2 in patients with severe COVID-19 would be desirable.

As mentioned, the severity of COVID-19 is also associated with high levels of phospholipase A2. Flavonoids specifically affect the activity of inflammatory enzymes, which include phospholipase A2, cyclooxygenases, lipooxygenases, tyrosine kinase, serine-threonine protein kinase, phospholipase C, thus reducing the concentrations of crucial mediators of inflammation such as arachidonic acid, prostaglandins, leukotrienes, and NO. Phospholipase A2 (PLA2) is an enzyme that catalyzes the hydrolysis of membrane phospholipids, releasing free fatty acids and lysophospholipids. There are six main groups of phospholipases A2: secretory (sPLA2), cytosolic (cPLA2), calciumindependent (iPLA2), platelet-activating factor acetyl hydrolases (PAF-AH), lysosomal PLA2 (LyPLA2), and adipose-specific PLA2 (AdPLA2), including their different isoforms (Murakami et al., 2014) . Phospholipase A2 classification and pathologies associated with secretory PLA2 are reported by Quach, Arnold, and Cummings (2014) .

The best-known flavonoid that inhibits sPLA2-II is quercetin (Lattig et al., 2007; Lesjak et al., 2018; Valerio et al., 2009) Tagesson, 1997). However, a weaker inhibition is observed with hesperidin, naringenin, apigenin, amentoflavone (Jin et al., 2020; Lee, Son, Chang, Kang, & Kim, 1997; Welton et al., 1986) . Known flavonoids inhibiting sPLA2-IIA activity include a group of biflavonoids such as ochnaflavone, amentoflavone which inhibit the enzymatic and biological activities of sPLA2-IIA (Chang et al., 1994; Moon et al., 2002) .

Ginkgetin reduces a pro-inflammatory gene expression such as induc- Post-COVID-19 symptoms include long-term health problems with lungs, heart, brain, kidney, and digestion. In some patients, there is a presumption of post-COVID-19 chronic diseases associated with damaged lungs, heart, brain, and persistent problems with blood clotting, impaired immune system. All of this is related to clinical manifestations, especially myalgia, intense fatigue, the sensation of fever, shortness of breath, chest tightness, tachycardia, headaches, and anxiety (Davido, Seang, Tubiana, & de Truchis, 2020; Oronsky et al., 2021) , which could persist for several years, as it was the case in the 2003 SARS epidemic (P. .

Not only the elderly and people with many serious health problems but also younger people may develop persistent post-COVID-19

symptoms. Even for weeks or months after infection. These people are referred to as "long haulers." At present, it is not yet possible to say what long-term consequences it may have or whether they are temporary or permanent. This condition is also called "Long covid" or post-COVID-19 syndrome.

The most common complications of patients seeking medical attention after COVID-19 include muscle pain, severe fatigue, chronic fatigue, sleep disturbances, persistent fever, chronic cough, chest pain, palpitations, joint pain, headache and anxiety, mood swings, cognitive dysfunction (memory disorders), taste and smell disorders, diarrhea, hair loss In chronic diseases, studies such as cancer, obesity, liver, and

Alzheimer's disease associated with inflammation significant progress was made. This is primarily done by investigating inflammasome Weerahandi has found that even a month after patients were discharged, more than 70% of post-COVID-19 patients reported shortness of breath, and 13.5% were still using oxygen at home (Weerahandi et al., 2021) . Other reports state that 43% of patients in Italy suffered from persistent dyspnea an average of 60 days after symptom onset (Carfi et al., 2020) . In France, 42% of COVID19 survivors had dyspnea an average of 111 days after hospital admission (Garrigues et al., 2020) . The highest risk to develop lung fibrosis is in an elderly patient who requires ICU care and mechanical ventilation. Currently, no fully proven options for postinflammatory COVID-19 pulmonary fibrosis (Rai et al., 2021) . Pulmonary fibrosis is preceded by cytokine storm, and dysregulated release of matrix metalloproteinases is a known consequence of acute respiratory distress syndrome (ARDS). It has been found that 40% of patients with COVID-19 develop ARDS, and 20% of ARDS cases were severe (Rai et al., 2021; Wu et al., 2020) . Although Flavonoids can also be used to support respiratory disease treatment. Several studies confirm the antifibrotic potential of flavonoids (Cordoba et al., 2015) . Apigenin (L. Chen & Zhao, 2016) , epigallocatechin (EGCC) (Sriram, Kalayarasan, & Sudhandiran, 2009) and quercetin (Baowen et al., 2010) are flavonoids that reduce bleomycin-induced pulmonary fibrosis. Grape seed extract recovers lung fibrosis by inhibiting of inflammatory cytokine TGF-β1 and metalloproteinase MMP-9 expression (Liu et al., 2017) .

Leaf extract of flavonoid-rich antioxidant Ginkgo biloba improves blood flow, protects from free radicals, blocks platelet aggregation and blood clotting (Dubey, Shankar, Upadhyaya, & Deshpande, 2004; Ernst, 2002; Mahady, 2002) . It also has been examined for antifibrotic effect in the bleomycin model ( Post-COVID-19 patients often come to the outpatient clinics due to increased blood pressure. The flavonoids are a great source of functional antihypertensive products (L. Guerrero et al., 2012) . Data showed that daily consumption of 150 mg quercetin for 6 weeks reduced systolic blood pressure and simultaneously decreased plasma concentrations of atherogenic oxidized LDL (Egert et al., 2009 (Cassidy et al., 2011) .

A significant complication of the post-COVID-19 syndrome is the persistent presence of blood clots. Flavonoids have a place in this area too. The effect of flavonoids is antithrombotic, anti-platelet (J. A. Guerrero et al., 2005) , and anticoagulant (Correia-da-Silva et al., 2011; Kumar, Narwal, Kumar, & Prakash, 2011 . Flavonoids can modulate platelet function through many pathways. The mechanism of flavonoids action is through binding of flavonoids to TXA2 (Muñoz, Garrido, & Valladares, 2009 #145) , which decreases the levels of TXA2 related to the inhibition of COX-1-genistein, daidzein, equol (Corvazier & Maclouf, 1985) , and kaempferol (H. Wang et al., 2000) .

Another way is the induction of conformational changes of GPIIb/IIIa receptors with epicatechin (Pearson et al., 2005) , tangeritin, naringin, and naringenin (Holt, Actis-Goretta, Momma, & Keen, 2006) , and occupation of GPIIb/IIIa receptors. The most significant antiplatelet activity was shown by flavonoids naringin, naringenin, and coumarins such as franxetin and esculetin. It has been revealed that naringin showed a considerably high ability to interact with GPIIb/IIIa receptors (Zaragoza et al., 2016) . The effective antithrombotic agents seem to be quercetin and rutin found in apples (Gryglewski, Korbut, Robak, & Swies, 1987; Shafi et al., 2019) , kaempferol, and tiliroside from raspberry leaves (N. Han et al., 2012) myricetin, fisetin, and morin from white mulberry (Tzeng, Ko, Ko, & Teng, 1991) .

Because of increased bleeding, which could be a severe adverse effect, only a clinical study will show whether it is appropriate to deliver flavonoids with anticoagulant ability to post-COVID-19

patients. In most COVID-19 patients, the coagulation pathways are usually activated. Some patients may uncommonly develop subarachnoid hemorrhage due to COVID-19 (Batcik et al., 2021) . Therefore, flavonoids should be used with caution in patients with COVID-19 or post-COVID-19.

The development of mental disorders such as depression and anxiety are predisposed by genetic background, biological factors, and the population's epidemiologic, social, and economic situation. Headaches and anxiety, depression, mood swings, cognitive dysfunctionmemory disorders, chronic fatigue, and sleep disorders (Fu et al., 2020; Pandharipande et al., 2013; Zhou et al., 2020) Flavonoids and their derivatives-flavonoid glycosides as antiinflammatory agents can affect the CNS-mediated activities associated with neurochemical changes. Particularly as either sedativehypnotics, analgesics, or both. It was revealed that the flavonoid glycosides such as hesperidin, linarin, naringin, diosmin, neohesperidin, and gossypin induce CNS depressant action in mice (Fernandez et al., 2006; Fernandez et al., 2009) . The maximal anxiolytic effect of flavones was reached at the 10 mg/kg concentration without sedation, myorelaxation, or significant reduction in locomotor activity (Fernandez et al., 2006; Marder & Paladini, 2002) . Low doses of gossypin and naringin induced a strong anxiolytic effect comparable to diazepam 2 mg/kg. At high doses, both flavonoids caused sedative effects. Moreover, naringin also possesses myorelaxant activity (Fernandez et al., 2006) . Another study has shown that baicalein, directly injected into the mice CNS, promoted anxiolytic-like and sedative effects (de Carvalho, Duarte, & de Lima, 2011) . Flavonoids as natural products are classified as new effective antidepressant drugs.

A significant antidepressant-like mechanism of hesperidin has been revealed in mice exposed to chronic mild stress (C. F. Li et al., 2016) . Not surprisingly, many COVID-19 patients required kidney replacement therapy (F. Jiang, Zhang, Xie, Zhang, & Wang, 2019) , and post-COVID regeneration in such patients took much longer. Kidney involvement in SARS-CoV-2 infection is associated with kidney tubular injury, impaired glomerular filtration, and manifests as proteinuria, hematuria with increased serum creatinine and urea nitrogen level (X. Han & Ye, 2021; Naicker et al., 2020) . In a study by Richardson et al., 454 of 5, patients had underlying kidney disease, of which 81 patients were treated by renal replacement therapy (Richardson et al., 2020) .

Regarding renoprotective effectiveness, flavonoids are wellknown antihypertensive substances that promote diuresis and natriuresis. Rutin can be found in onion, apples, red wine, tea, citrus fruit, and figs. It may decrease elevated blood pressure, cardiac fibrosis, left ventricular stiffness, hypertrophy, normalize plasma uric acid, ameliorate renal fibrosis and proteinuria. Thus, improve creatinine clearance and normalize plasma creatinine concentrations (Diwan, Brown, & Gobe, 2017; Y. Han, Lu, Xu, Zhang, & Hong, 2015; Panchal, Poudyal, Arumugam, & Brown, 2011) . Oral administration of pectolinaringenin from the aerial parts of Cirsium chanroenicum remarkably improved kidney tubular injury after unilateral ureteral obstruction via inhibition of TGFβ/SMAD3 and JAK2/STAT3 signaling (Y. Li, Guo, Huang, Ma, & Fu, 2021) . Astragali radix (AR) root extract from Astragalus membranaceus (Fisch.) is a well-known source of flavonoids used for the anti-nephrotic syndrome (L. P. Chen, Zhou, & Yang, 2004) . In addition to its antiinflammatory, anticancer, and diuretic action, AR which happened in 2012 (Assiri et al., 2013; Leung et al., 2003) . While the presence of SARS-CoV-19 in the gastrointestinal tract is demonstrated in COVID-19 patients, despite multiple SARS-CoV-2 RT-PCR tests performed on oropharyngeal and nasopharyngeal swab samples, were COVID-19 negative (Brogna et al., 2021) and without respiratory syndrome (Jin et al., 2020) . A virus was detected in the feces, thus confirming its feco-oral transmission (Y. . In some patients' endoscopic examination confirmed the ulcers and bleeding in gastrointestinal tissues associated with COVID-19. The most severe complication of COVID-19 related to the ACE2 receptors on pancreatic islets and cytokine storm is pancreatic injury related, resulting in a higher incidence of anorexia and diarrhea .

Due to the highly expressed ACE2 receptors in the colonic tissue, it is expected that patients will be at risk of further GI complications after overcoming COVID-19 infection. Gastrointestinal sequelae due to COVID-19 involved loss of appetite, nausea, acid reflux, and diarrhea. They were common in patients 3 months after discharge from hospitalization (J. Weng et al., 2021) .

Pancreatic cells express the ACE receptor of SARS-CoV-2 on their surface. The risk of viral damage to the pancreas is high. The association between COVID-19 and acute pancreatitis or pancreas injury is based on evidence provided by many authors (Aloysius et al., 2020; Anand, Major, Pickering, & Nelson, 2020; Lattig et al., 2007; Samies, Yarbrough, & Boppana, 2021; Kumar et al., 2011; Sarian et al., 2017) . Significant preventive antidiabetic effect of flavonoids was observed in quercetin and chrysin (Lukačínová et al., 2008) , apigenin (Panda & Kar, 2007) , baicalein (Keshari et al., 2016) , hesperidin, and naringin et al., 2020) . Liver infection in patients with COVID-19 directly contributes to hepatic impairment and is manifested by microvesicular steatosis and mild lobular and portal activity . The most liver damage is of hepatocellular type . The other significant liver damage is antiviral drug-induced and is potentially hepatotoxic (Piszczatoski & Powell, 2020) . After a morin administration, a remarkable effect was observed in rats with IFOS-induced liver injury. Morin, found in white berry and cranberry branches, decreases the levels of hepatic enzymes AST, ALP, and ALT, reduces the lipid peroxidation product-malondialdehyde, and decreases the levels of inflammatory markers (Ozdemir, Kucukler, Comakli, & Kandemir, 2020) . Ternatin, silymarin, quercetin, glycone (rutin), gossypin, and hydroxyetilrutinoside display a vigorous antihepatotoxic activity (Kvasnička, Bíba, Ševčík, VoldŘich, & Krátká, 2003; Rao et al., 1994; Sikder, Kesh, Das, Manna, & Dey, 2014; Vijayaraghavan, Sugendran, Pant, Husain, & Malhotra, 1991) . This study is aimed to instigate a more rigorous interest in flavonoids research and support the hypothesis that flavonoids could represent an excellent supportive care strategy specifically for patients suffering from the post-COVID-19 syndrome. The list flavonoids holding therapeutic and prophylactic properties, which may potentially modulate the post post-COVID-19 syndrome outcome, is presented in Table 1 .

This publication results from the project implementation: "Open scientific community for modern interdisciplinary research in medicine (OPENMED)," ITMS2014+: 313011V455 supported by the Operational Programme Integrated Infrastructure, funded by the ERDF.

The authors declare no conflicts of interest.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0003-4594-3363

NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases

Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis

Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats

Dietary fruits and vegetables and cardiovascular diseases risk

COVID-19 presenting as acute pancreatitis

Liver function recovery of COVID-19 patients after discharge, a follow-up study

Acute pancreatitis in a COVID-19 patient

Rutin modulates ASC expression in NLRP3 inflammasome: A study in alcohol and cerulein-induced rat model of pancreatitis

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study

Recent advances in understanding the anti-diabetic actions of dietary flavonoids

Heart failure and COVID-19

The SARScoronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds

A further investigation concerning correlation between antifibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis

COVID-19 infection produces subarachnoid hemorrhage; acting now to understand its cause: A short communication

Angiotensin II revisited: New roles in inflammation, immunology and aging

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis

Quercetin inhibits advanced glycation end product formation via chelating metal ions, trapping methylglyoxal, and trapping reactive oxygen species

Chrysin promotes attenuation of depressive-like behavior and hippocampal dysfunction resulting from olfactory bulbectomy in mice

Botanical drugs and supplements affecting the immune response in the time of COVID-19: Implications for research and clinical practice

SARS-CoV-2 detection in fecal sample from a patient with typical findings of COVID-19 pneumonia on CT but negative to multiple SARS-CoV-2 RT-PCR tests on oropharyngeal and nasopharyngeal swab samples

Flavonoids as antioxidants and developmental regulators: Relative significance in plants and humans

COVID-19: Abnormal liver function tests

Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms

Persistent symptoms in patients after acute COVID-19

Anti-depressant-like effect of kaempferitrin isolated from Justicia spicigera Schltdl (Acanthaceae) in two behavior models in mice: Evidence for the involvement of the serotonergic system

Habitual intake of flavonoid subclasses and incident hypertension in adults

Post COVID inflammation syndrome: Different manifestations caused by the virus

Inactivation of phospholipase A2 by naturally occurring biflavonoid

A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention

Luteolin ameliorates experimental lung fibrosis both in vivo and in vitro: Implications for therapy of lung fibrosis

Potential natural compounds for preventing 2019-nCoV infection

Myricetin inhibits NLRP3 inflammasome activation via reduction of ROS-dependent ubiquitination of ASC and promotion of ROSindependent NLRP3 ubiquitination

Apigenin protects against bleomycin-induced lung fibrosis in rats

Protective effects of astragali injection on tubular in patients with primary nephrotic syndrome

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation

The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients

Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies

Bimodal action of the flavonoid quercetin on basophil function: An investigation of the putative biochemical targets

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship

Flavonoid-modified surfaces: Multifunctional bioactive biomaterials with osteopromotive, antiinflammatory, and anti-fibrotic potential

Flavonoids with an oligopolysulfated moiety: A new class of anticoagulant agents

Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative-metabolism of Arachidonic-acid by human-platelets and neutrophils

Effects of L-carnitine and ginkgo biloba extract (EG b 761) in experimental bleomycin-induced lung fibrosis

Antiviral efficacy of flavonoids against Enterovirus 71 infection in vitro and in newborn mice

Post-COVID-19 chronic symptoms: A postinfectious entity?

Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice

Luteolin mediates the antidepressant-like effects of Cirsium japonicum in mice, possibly through modulation of the GABAA receptor

Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: A retrospective cohort study. Microorganisms

Is COVID-19 a new hematologic disease?

Inhibitory activities of baicalin against renin and angiotensin-converting enzyme

A role for quercetin in coronavirus disease 2019 (COVID-19)

The flavonoid rutin improves kidney and heart structure and function in an adenine-induced rat model of chronic kidney disease

Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system

Ginkgo biloba--an appraisal

Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study

Polyphenols are potential nutritional adjuvants for targeting COVID-19

Flavonoids and heart health

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, ginseng, Echinacea, saw palmetto, and kava

Diet enriched with procyanidins enhances antioxidant activity and reduces myocardial post-ischaemic damage in rats

Cytokines in acute and chronic inflammation

The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice

Central nervous system depressant action of flavonoid glycosides

Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan

Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties

Oroxylin a is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from radix Scutellariae using angiotensinconverting enzyme II/cell membrane chromatography

Baicalein attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of miR-21

The antiinflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang liver cells

Post-discharge persistent symptoms and healthrelated quality of life after hospitalization for COVID-19

A study on anti-SARS-CoV 3CL protein of flavonoids from litchi chinensis sonn core

Polyphenols as mitochondria-targeted anticancer drugs

Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2

On the mechanism of antithrombotic action of flavonoids

Antioxidant properties of catechins: Comparison with other antioxidants

Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor

Inhibition of angiotensinconverting enzyme activity by flavonoids: Structure-activity relationship studies

Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor

Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii)

Kidney involvement in COVID-19 and its treatments

Rutin ameliorates renal fibrosis and proteinuria in 5/6-nephrectomized rats by antioxidation and inhibiting activation of TGF β1-smad signaling

Dietary antioxidant flavonoids and risk of coronary heart-disease -the Zutphen elderly study

Flavonoid-rich extract of Actinidia macrosperma (A Wild Kiwifruit) inhibits angiotensin-converting enzyme in vitro

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

Dietary flavanols and platelet reactivity

Concentration-dependent effect of silymarin on concanavalin A-stimulated mouse spleen cells in vitro

6-month consequences of COVID-19 in patients discharged from hospital: A cohort study

The multifunctional effects of nobiletin and its metabolites in vivo and in vitro

Polyphenol protection and treatment of hypertension

The discovery of angiotensinconverting enzyme 2 and its role in acute lung injury in mice. Experimental

Targeting angiotensin-converting enzyme-2/angiotensin-(1-7)/Mas receptor axis in the vascular progenitor cells for cardiovascular diseases

ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia

Planning for the post-COVID syndrome: How payers can mitigate long-term complications of the pandemic

The effect and clinical significance of continuous renal replacement therapy on sepsis and liver and kidney functions

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms

Effect of kaempferol on cyclooxygenase 2 (Cox2) and cytosolic phospholipase A2 (cPLA2) protein expression in BALB/c mice

Antiviral effect of flavonoids on human viruses

Fruit peel polyphenolic extract-induced apoptosis in human breast cancer cells is associated with ROS production and modulation of p38MAPK/Erk1/2 and the Akt signaling pathway

Isolated flavonoids from Ficus racemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar rats

In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro)

Antiinflammatory plant flavonoids and cellular action mechanisms

Flavonoid intake and risk of chronic diseases

Alpha-glucosidase inhibitors from plants: A natural approach to treat diabetes

Analysis of the active components of silymarin

Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity

Structure-activity association of flavonoids in lung diseases

Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats

Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: Rationale for lead design

Inhibition of arachidonate release from rat peritoneal macrophage by biflavonoids

Pathophysiology of COVID-19-associated acute kidney injury

Antioxidant and antiinflammatory activities of quercetin and its derivatives

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

Flavonoids as cytokine modulators: A possible therapy for inflammation-related diseases

ERK-dependent brain-derived neurotrophic factor regulation by hesperidin in mice exposed to chronic mild stress

Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects

Ginkgetin exerts antiinflammatory effects on cerebral ischemia/reperfusion-induced injury in a rat model via the TLR4/NF-kB signaling pathway

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Natural flavonoid pectolinarigenin alleviated kidney fibrosis via inhibiting the activation of TGFbeta/SMAD3 and JAK2/STAT3 signaling

Flavonoids interfere with NLRP3 inflammasome activation

Chrysin, a natural and biologically active flavonoid, influences a murine leukemia model in vivo through enhancing populations of T-and B-cells, and promoting macrophage phagocytosis and NK cell cytotoxicity

Identification and quantification of flavonoids of Mexican oregano (Lippia graveolens) by LC-DAD-ESI/MS analysis

The protective effect of naringenin on airway remodeling after Mycoplasma pneumoniae infection by inhibiting autophagy-mediated lung inflammation and fibrosis

Flavonoids as phospholipase A2 inhibitors: Importance of their structure for selective inhibition of group II phospholipase A2

Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis

Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae)

Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases

SARS-CoV-2 another kind of liver aggressor, how does it do that?

Preventive effects of flavonoids on alloxan-induced diabetes mellitus in rats

Antidepressant activity of astilbin: Involvement of monoaminergic neurotransmitters and BDNF signal pathway

Ginkgo biloba for the prevention and treatment of cardiovascular disease: A review of the literature

Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study

The correlation between antimutagenic activity and total phenolic content of extracts of 31 plant species with high antioxidant activity

Anti-inflammatory effects of flavonoids

GABA(A)-receptor ligands of flavonoid structure

Apigenin supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways

Antihypertensive effects of flavonoids isolated from brazilian green propolis in spontaneously hypertensive rats

Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor

Flavonoids activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity

Flavonoid inhibition of human basophil histamine release stimulated by various agents

The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer

The effect of quercetin on light-induced cytotoxicity of hypericin

Antimutagenic activity of flavonoids from Chrysanthemum morifolium

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge

The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Inhibitory activity of amentoflavone on arachidonic acid releasing enzyme, Phopholipase A2 and inhibition of histamine release from mast cells

Natural flavonoids as potential angiotensin-converting enzyme 2 inhibitors for anti-SARS-CoV-2

Inhibition of cytosolic phospholipase A2 alpha impairs an early step of coronavirus replication in cell culture

Equol is more active than soy isoflavone itself to compete for binding to thromboxane A2 receptor in human platelets

Emerging roles of secreted phospholipase A (2) enzymes: The 3rd edition

The novel coronavirus 2019 epidemic and kidneys

Inhibitory effect of baicalein, a flavonoid in Scutellaria root, on eotaxin production by human dermal fibroblasts

Effects of propolis from different areas on mast cell degranulation and identification of the effective components in propolis

Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris

Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa

Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS-CoV-2 drug targets: In vitro validation of furin inhibition

A review of persistent post-COVID syndrome (PPCS)

Prognosis of COVID-19 in patients with liver and kidney diseases: An early systematic review and meta-analysis

The protective effect of Morin against ifosfamide-induced acute liver injury in rats associated with the inhibition of DNA damage and apoptosis

Phytopharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property

Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate high-fat diet-fed rats

Apigenin (4 0 ,5,7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxaninduced diabetic mice

Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development

Long-term cognitive impairment after critical illness

Molecular and functional resemblance of dexamethasone and quercetin: A paradigm worth exploring in dexamethasone-nonresponsive COVID-19 patients

Flavanols and platelet reactivity

Selected nutraceutic screening by therapeutic effects on doxorubicin-induced chronic kidney disease

The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide

Emergency authorization of chloroquine and hydroxychloroquine for treatment of COVID-19

Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)

Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease

Post covid 19 pulmonary fibrosis. Is it real threat?

Protective effect of ternatin, a flavonoid isolated from Egletes viscosa less, in experimental liver-injury

Inhibition of LOX by flavonoids: A structureactivity relationship study

Structure-antioxidant activity relationships of flavonoids and phenolic acids

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area

The flavonoid rutin but not the alkaloid arborinine induces apoptosis in a B-cell hybridoma cell line

Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19

Procyanidins: A comprehensive review encompassing structure elucidation via mass spectrometry

Roles of flavonoids against coronavirus infection

Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of loadinduced chronic fatigue syndrome

Pancreatitis in pediatric patients with COVID-19

Cardiovascular effects of flavonoids

Vasorelaxant and antihypertensive activities of citroflavonoids (Hesperidin/Naringenin mixture): Potential prophylactic of cardiovascular endothelial dysfunction

New perspectives on natural flavonoids on COVID-19-induced lung injuries

Antioxidant and antidiabetic effects of flavonoids: A structure-activity relationship based study

Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis

High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome

Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus

Variability in catechin and rutin contents and their antioxidant potential in diverse apple genotypes

The high antioxidative power of quercetin (aglycone flavonoid) and its glycone (rutin) avert high cholesterol diet induced hepatotoxicity and inflammation in Swiss albino mice

Group IIA secreted phospholipase A2 plays a central role in the pathobiology of COVID-19

Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis

Persistent symptoms 1.5-6 months after COVID-19 in nonhospitalised subjects: A population-based cohort study

Effects of apigenin on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats

Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean

Inhibition of Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin

Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts

Dexamethasone for COVID-19? Not so fast

The effects of morin on lipopolysaccharide-induced acute lung injury by suppressing the lung NLRP3 inflammasome

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis

Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19

Inhibition of platelet aggregation by some flavonoids

New-onset type 1 diabetes in children during COVID-19: Multicenter regional findings in the U.K. Diabetes Care

Quercetin reduces inflammatory pain: Inhibition of oxidative stress and cytokine production

A safety study of oral tangeretin and xanthohumol administration to laboratory mice

Markers of oxidative stress and neuroprogression in depression disorder

Late acute pulmonary embolism after mild coronavirus disease 2019 (COVID-19): A case series

Modulation of antigen-induced chronic fatigue in mouse model of water immersion stress by naringin, a polyphenolic antioxidant

Dermal intoxication of mice with bis(2-chloroethyl)sulphide and the protective effect of flavonoids

Pancreatic injury patterns in patients with coronavirus disease 19 pneumonia

Cyclooxygenase active bioflavonoids from Balaton tart cherry and their structure activity relationships

Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst by cirsimaritin involves inhibition of phospholipase D signaling in rat neutrophils

Post-discharge health status and symptoms in patients with severe COVID-19

Icariin alters the expression of glucocorticoid receptor, FKBP5 and SGK1 in rat brains following exposure to chronic mild stress

Effect of flavonoids on arachidonic acid metabolism

Gastrointestinal sequelae 90 days after discharge for COVID-19

Effect of total flavonoid in leaves of Ginkgo biloba on the apoptosis of eosinophil in broncho alveloar lavage fluid

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Inhibition of LPSstimulated pathways in macrophages by the flavonoid luteolin

Antibacterial activities of flavonoids: Structure-activity relationship and mechanism

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Quercetin treatment improves renal function and protects the kidney in a rat model of adenine-induced chronic kidney disease

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method

Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase

Antiplatelet activity of flavonoid and coumarin drugs

Comparison of severe acute respiratory syndrome coronavirus 2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts

Tectorigenin inhibits the in vitro proliferation and enhances miR-338* expression of pulmonary fibroblasts in rats with idiopathic pulmonary fibrosis

Longterm bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study

Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system

The landscape of cognitive function in recovered COVID-19 patients

Antioxidative activity of flavonoids in stimulated human neutrophils

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy